Mesoblast (MESO) Gains from Investment Securities: 2017-2023
- Mesoblast's Gains from Investment Securities was N/A to -$4,000 in Q1 2023 from the same period last year, while for Mar 2023 it was -$32,000, marking a year-over-year change of. This contributed to the annual value of -$24,000 for FY2022, which is 31.43% up from last year.
- Per Mesoblast's latest filing, its Gains from Investment Securities stood at -$4,000 for Q1 2023, which was down 157.14% from $7,000 recorded in Q2 2022.
- Mesoblast's Gains from Investment Securities' 5-year high stood at $7,000 during Q2 2022, with a 5-year trough of -$29,000 in Q1 2021.
- In the last 3 years, Mesoblast's Gains from Investment Securities had a median value of -$4,000 in 2023 and averaged -$8,667.
- Data for Mesoblast's Gains from Investment Securities shows a maximum YoY plummeted of 625.00% (in 2021) over the last 5 years.
- Mesoblast's Gains from Investment Securities (Quarterly) stood at -$3,000 in 2019, then crashed by 100.00% to -$6,000 in 2020, then plummeted by 625.00% to -$29,000 in 2021, then reached $7,000 in 2022, then reached -$4,000 in 2023.
- Its Gains from Investment Securities stands at -$4,000 for Q1 2023, versus $7,000 for Q2 2022 and -$29,000 for Q1 2021.
